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Oestradiol-178 (E,) treatment of the ovariectomized mouse results in a synchronised wave of cell prolifera- 
tion in the uterine luminal epithelium. At the peak of DNA synthesis the mRNA level of the c-rasH proto- 
oncogene and ornithine decarboxylase were significantly increased. Progesterone treatment completely in- 
hibits the E, induced wave of DNA synthesis but does not greatly influence the level of these 2 mRNAs. 
Thus in the uterine luminal epithelium Ez regulates the level of ornithine decarboxylase and c-rasH indepen- 
dently of cell proliferation. 
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1. INTRODUCTION 
Over the years many proteins have been im- 
plicated as positive regulators of cell proliferation. 
Ornithine decarboxylase (ODC) the rate limiting 
enzyme of polyamine synthesis [l-3], was thought 
to play such a role [4,5] because of its short half- 
life and its rapid inducibility by proliferation 
signals [ 1,2]. Kinetic considerations, however, 
have shown that this enzyme is unlikely to be 
regulatory for the initiation of DNA synthesis 
although it appears to be an integral part of the 
growth pathway [6,7]. Now it is proposed that the 
proto-oncogenes play positive regulatory functions 
in cell proliferation because of their association 
with transforming retroviruses [B]. Indeed, one 
family of these proteins, the ras family, stimulates 
DNA synthesis when injected into fibroblasts in 
culture [9,10]. Because of this effect on DNA syn- 
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thesis and the association of rus with carcinomas 
[11,12] it is important to study the role of rm in 
epithelial tissues in vivo. A convenient system to 
do this is to use the luminal epithelium of the 
mouse uterus following treatment with female sex 
steroids. This is because oestradiol-17fl (Ez) given 
alone to ovariectomized adult mice induces a syn- 
chronised wave of DNA synthesis and cell division 
in this epithelium [13,14]. Four daily injections of 
progesterone however, completely inhibits this 
wave of cell proliferation [15] but has no effect on 
the time course or extent of the Ez stimulation of 
protein or rRNA synthesis [16,17]. Furthermore, 
since the luminal epithelium can be isolated with 
great purity from the underlying stroma [18] bio- 
chemical analysis may be performed on this tissue. 
Using this system we have shown that EZ induces 
the expression of c-rat? proto-oncogene and ODC 
independently of cell proliferation. 
2. MATERIALS AND METHODS 
Ovariectomized adult Schneider mice were 
primed with 2 injections of 100 ng E2 1 week 
before being killed and at least 2 weeks after 
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ovariectomy. After priming the mice were treated 
with one of the following hormone treatments 
[17,19] given sub-cutaneously in arachis oil. (i) 
Control animals given no hormone treatment. (ii) 
Animals given a single 50 ng injection of Ea 6 days 
after priming, a treatment that results in a syn- 
chronized wave of epithelial cell proliferation [14]. 
(iii) Animals given 4 daily injections of 1 mg pro- 
gesterone commencing 2 days after priming. (iv) 
Animals given progesterone as in (iii) with 50 ng Ez 
on the fourth day. This progesterone treatment 
completely suppresses the oestradiol induced wave 
of epithelial cell proliferation [ 151. At appropriate 
time thereafter, animals were killed and uterine 
luminal epithelial homogenates free from the re- 
mainder of the uterus prepared by the method of 
Fagg et al. [18]. From this homogenate total RNA 
was isolated by the method of Chirgwin et al. [20]. 
20 or 5Opg of total RNA, following formamide 
denaturation, was subjected to formaldehyde, 1 Vo 
agarose gel electrophoresis [21] using restriction 
digested lambda DNA, E. coli and Chorella 
ribosomal RNA as M, markers. Following elec- 
trophoresis the RNA was transferred to 
nitrocellulose and probed with either PBS-9 insert 
(rap) or pOD48 (ODC) nick translated with 
[32P]dCTP. Plasmids were isolated by the method 
of Birnboim and Doly [23] and further purified by 
ethidium bromide-caesium chloride centrifuga- 
tion. The plasmid PBS-9 [22] contained a 0.45 kb 
insert of the v-rap oncogene inserted in the EcoRI 
site of pBR322. This insert was purified from low 
melting point agarose gels after EcoRI digestion. 
pOD48 [24] contained a 1.6 kb cDNA insert 
homologous to most of the coding region of ODC 
and the whole plasmid was used in the hybridiza- 
tion reaction. Northern blots were probed with 
either of the above cloned sequences for 60 h at 
42°C using the conditions described by Taylor et 
al. [25]. The blots were washed to a final stringen- 
cy of 0.1 x SSC at 52”C, dried and subjected 
to autoradiography using Kodak X-Omat film 
with intensifying screens at -70°C. Resultant 
autoradiograms were scanned using a Zeineh soft 
scanning laser densitometer and the area under the 
scan determined from triplicate scans after the sub- 
traction of a background derived from an empty 
lane of the Northern blot. 
To estimate ODC enzyme activity luminal 
epithelial homogenates were prepared from 10 
310 
mice in the control group and 5 mice in the various 
treatment groups and ODC activity estimated by 
the method of Djurhuus [26]. Protein content was 
measured by the method of Lowry et al. [27]. The 
ODC assay was linear with protein content and 
over the time course of the assay. It was shown to 
be specific for ODC by the complete inhibition of 
activity with the irreversible competitive inhibitor 
of ODC, a-difluoromethylornithine [28]. 
3. RESULTS 
To assess the effect of E2 on c-t-as@ and ODC 
mRNA total uterine epithelial RNA was isolated 6 
and 12 h after Ez injection and subjected to Nor- 
thern blot analysis and the level of each of these 
mRNAs compared to the level in the untreated 
control. E2 increased the relative cytoplasmic con- 
tent of a single 1.4 kb mRNA species homologous 
to v-rap gene in the proliferative epithelium. 
There was a significant increase in mRNA at 6 h 
and a g-fold stimulation by 12 h (fig.1, table 1). 
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Fig.1. Analysis of the expression of c-r&’ in relation- 
ship to cellular proliferation in the mouse uterine 
luminal epithelium. Autoradiogram of a Northern blot 
of total uterine luminal epithelial RNA probed with a v- 
ru?r genomic clone. Each lane has 5Opg RNA isolated 
from the luminal epithelium of ovariectomized adult 
Schneider mice treated in the following ways (lanes): no 
treatment (l), a single 50 ng injection of Ez 6 h (2) or 
12 h (3) before being killed, animals given 1 mg pro- 
gesterone per day for 4 days (4), or given 50 ng Ez after 
4 previous daily treatments of progesterone and killed 6 
(5) or 12 h (6) after injection. 
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Densitometric quantitation of the levels of c-rap and ornithine decarboxylase mRNA from the Northern 
blot analysis 
Hormone Hours after Area under the scan (mm’) 
treatment oestradiol-17@ 
c-rap (1.4 kb) ODC (2.2 kb) 
Oestradiol-17fl 0 142 377 (-1 36 98 (-) 
alone 6 432 1325 (3.3) 143 608 (5.1) 
12 1264 3163 (8.7) 665 2761 (23.3) 
Progesterone: 0 435 1245 (3.2) 248 950 (8.3) 
oestradiol-17fl 6 745 1871 (5.1) 355 904 (9.5) 
12 1283 2799 (8.3) 628 1591 (16.81 
20 pg (1) or 50 pg (2) of total RNA isolated from mouse uterine epitheliai cells was subjected to Northern 
blot analysis and autoradiograms quantitated using a Zeineh soft laser scanning densitometer. The average 
factorial increase from the 2 RNA samples shown (in parentheses) is the amount of stimulation compared 
to the luminal epithelial mRNA level in a relevant untreated ovariectomized control. Staining of parallel 
tracks with toludine blue showed that the amount of RNA in each track was indistinguishable 
Progesterone, however, despite its complete inhibi- 
tion of DNA synthesis [IS] did not significantly ef- 
fect the accumulation of this mRNA in response to 
Ez (fig. 1, table 1). In fact even in the absence of Ez 
progesterone caused a reproducible elevation in the 
c-tafl mRNA level (table 1). A similar pattern of 
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Fig.2. Analysis of the level of ornithine decar~xyl~e 
mRNA in the mouse uterine epithelium. 5Or_rg total 
RNA isoiated from the epithelium of animals given the 
hormone regimes described in fig.1 was subjected to 
Northern gel analysis and probed with a 32P nick 
translated pOD48 plasmid. Lanes l-6 are comparable to 
those described in fig. 1. 
response was observed with ODC mRNA. In this 
case the mRNA level was stimulated by Et 5-fold 
at 6 h and 23-fold by the peak of DNA synthesis 
(fig.2 and table 1). Four days of progesterone 
treatment failed to prevent the increase in mRNA 
level and, in fact, caused an &fold increase even in 
the absence of Ez. The major mRNA species was 
a band of approx. 2.2 kb, Upon longer exposures 
a higher-M, band at 2.7 kb was also detected at an 
elevated level following EZ treatment. A band at 
1.8 kb was also observed whose relative content 
was also increased by EZ treatment but interesting- 
ly not following progesterone pretreatment. We 
also measured ODC enzyme activity 1261 during 
the first 6 h of E2 treatment. ODC activity under- 
went a dramatic stimulation within 4 h of Et treat- 
ment, reaching a 60-fold stimulation within 6 h. 
Progesterone pretreatment did not inhibit this E:! 
induced increase in activity which under this 
regime showed a 75fold increase within 6 h. In- 
terestingly again, progesterone stimulated the en- 
zyme activity to a small extent in the absence of Ez. 
4. DISCUSSION 
Ez induces luminal epithelial DNA synthesis 
which begins 6-8 h after administration of the hor- 
mone and reaches a maximum at 12-15 h [13,14]. 
At this time essentially all the cells are engaged in 
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DNA synthesis. By 15 h the cells enter into mitosis 
and the cell number doubles (131. Progesterone 
pretreatment, however, completely suppresses this 
proliferative response [15]. Ez induced a major 
2.2 kb ODC mRNA band and minor 2.7 and 
1.8 kb bands in the luminal epithelium. The major 
and minor bands are similar to those observed in 
other mouse tissues [24,29,30] and may represent 
alternatively spliced mRNAs or transcripts from 
different ODC genes. The pattern of EZ stimula- 
tion of ODC enzyme activity was comparable to 
that described in other tissues exposed to growth 
factors [31] and to that described in the whole im- 
mature rat uterus in response to Ez [32]. Quan- 
titatively however, the increased level of ODC 
mRNA seems unlikely to explain all the stimula- 
tion of the ODC enzyme activity (tables 1 and 2) 
suggesting that Ez also affects the activity or 
stability of this enzyme. In other cell types treated 
with growth factors a modulation of both these 
paramaters resulting in increased ODC levels has 
been described [3 11. 
This pattern of ODC stimulation which is closely 
correlated with an increase in cell growth and not 
with cell proliferation suggests that ODC is unlike- 
ly to be directly involved in the regulation of cell 
division as has been concluded by other workers 
[5,6]. It might however, be indirectly involved 
since Russell (331 has presented evidence that ODC 
is a stimulatory factor for RNA polymerase I. In- 
creased rRNA synthesis is invariably seen in cells 
stimulated to divide and may explain why there is 
such a large stimulation of ODC activity over and 
above the apparent requirement for polyamines 
following mitogen treatment. The lack of correla- 
tion seen between ODC activation, rRNA synthesis 
and cell proliferation [17,34] in the luminal 
epithelium may be explained by the recent observa- 
tions that cell growth and cell proliferation are in- 
dependently but coordinately regulated pathways 
[17,35]. Thus the former 2 events would normally 
be associated with cell proliferation but can be 
regulated independently from it. It should be 
pointed out, however, that ODC activation lags 
behind the Ez stimulation of rRNA synthesis. A 
dissociation of time course between cell growth 
and ODC activity has also been described in the 
immature rat uterus following Ez treatment [36]. 
This dissociation might suggest that these 2 events 
are not casually linked. 
Proto-oncogenes, however, are currently 
thought to be positive regulators of cell prolifera- 
tion by enabling cells to traverse critical regulatory 
points in the cell cycle 1371. EZ induced an ac- 
cumulation of c-rap mRNA in the mouse uterine 
epithelium in a pattern similar to that described for 
other cell types [38,39]. In contrast to these other 
cell types however, the epithelial cells did not 
Table 2 
The activity of ornithine decarboxylase in the mouse uterine iuminal epithelium following various hor- 
monal treatments 
Time following Hormone treatment 
oestradiol- 17fi 
treatment Oestradiol-I 7,# alone 
Progesterone: oestradiol-17@ 
(h) Enzyme activity Fold Enzyme activity Fold 
stimulation stimulation 
0 11 + 3 (16) - 54 f 16 (4)b 4.9 
2 18 + 3 (4)’ 1.6 84+ 15 (4)b 7.6 
4 232 + 58 (lO)b 21.1 390 Zk 52 (4)b 35.5 
6 653 + 36 (4)b 59.4 832 f 101 (4)b 75.6 
The enzyme activity expressed as pmol/h per mg of protein +_ SE of the mean was determined by the 
method of Djurhuus [26]. The fold stimulation is the degree of elevation of the enzyme activity observed 
at a specific time after E2 treatment over that determined in the untreated ovariectomized luminal 
epithelium. The following degrees of significance were obtained when the activity from hormone-treated 
animals was compared to the untreated control: “not significant, “p < 0.01. The number in parentheses 
represents the number of observations 
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necessarily proceed to DNA synthesis and cell pro- 
liferation. It would also seem unlikely therefore 
that c-r&’ is a positive regulator of DNA synthesis 
acting independently of other controls, at least in 
the uterine luminal epithelium. Recent data has 
suggested that ras is a guanine nucloetide-binding 
protein [40] analogous to the G-protein known to 
regulate adenylate cyclase activity [41]. It may 
therefore act as a membrane signal transducer in- 
volved in preparing cells for division [42]. Perhaps 
this is achieved by stimulating the production of 
receptors to other growth factors to allow cells to 
progress towards DNA synthesis or by signalling 
for an elevated level of metabolic rate which is nor- 
mally necessary for DNA synthesis initiation. 
Evidence favouring the latter role comes from the 
observation that progesterone treatment in the 
absence of E2 produced a small increase in protein 
and rRNA synthesis [17] and c-ras” mRNA but 
completely inhibited the basal level of cell pro- 
liferation [15,43]. Since in a normal epithelial 
tissue c-ru.s” is not an obligatory cell cycle protein 
it is of considerable interest to understand how the 
function of a mutant ras protein [44,45] avoids the 
negative controls of other growth regulators and 
causes carcinomas in vivo. 
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